Valeant Pharmaceuticals’ stock dive “is a gross overreaction in the market caused by charges thus far that are unsubstantiated and denied by Valeant," says Smith School finance professor David Kass, a long-time observer of Valeant stock and former health economist for the Federal Trade Commission. Read more...
Fall 2015 edition of Smith Business magazine.
When it comes to generating revenue, the U.S. health care system sometimes rewards quantity over quality. Fixing the flawed incentives will require greater transparency about the costs and values of services, experts said Oct. 9-10, 2015, at the sixth annual Workshop on Health IT and Economics, hosted by the Center for Health Information and Decision Systems (CHIDS) at the University of Maryland’s Robert H. Smith School of Business.
Want to talk about who is overpaid or underpaid at your office, or gripe about long hours or working conditions? You can, according to the National Labor Relations Board. But a well-run company with fair compensation practices shouldn't be overly worried if its employees talk about pay, says Smith School professor Hui Liao. She says pay gaps, particularly those based on merit, can motivate people.